Explainable AI to tackle the complexities of drug discovery

Our technology is designed to help scientists pinpoint novel targets for the right patients for any disease. Robust evidence explains how AI is helping reach these decisions, enhancing confidence and increasing portfolio success rate. We now provide the ability to integrate this technology into your own platform via our API offering.

End-to-end Drug Discovery

Explore opportunities

versatile, scalable and robust AI-enabled drug discovery platform

  • Multimodal data intergration
  • Biomedical language comprehension 
  • Questioning and answering deep learning models 
  • Model recommendations through evidence explainability 
BenAI Engine.png

AI FOUNDATIONS

BenAI Engine

BenAI Engine is the core foundation of our technology that turns fragmented scientific data into actionable insights. 
It is designed to ingest, organise, and leverage biomedical data for a nuanced understanding of disease biology. 

Learn more

BENEFITS

Proven to enhance drug discovery

Benefit-1.svg
DISEASE AGNOSTIC

We can work on any therapeutic area due to the breadth and diversity of our data foundations.

Benefit-2.svg
MODALITY AGNOSTIC

The Benevolent Platform™ can be applied to antibody and biologic targets, in addition to small molecule targets, to further diversify our portfolio.

Benefit-3.svg
IDENTIFIES NOVEL TARGETS

Our predictive tools can surface targets that have never been considered for a disease before – and spark creativity in scientists.

Benefit-4.svg
ACCELERATES DISCOVERY

Through the combined capabilities of our AI Platform, scientific expertise and wet lab facilities we can rapidly identify and validate targets and reduce drug development timelines.

Benefit-5.svg
BUILT FOR SCALE

Our scalable, repeatable approach can support multiple in-house drug programmes and commercial collaborations.

Benefit-6.svg
POTENTIAL TO INCREASE PROBABILITY OF SUCCESS

Scientists use our tools to build higher confidence hypotheses in the earliest stages of drug discovery, with the aim of reducing costly failures down the line.

DSC01657.jpg

WET LABS

State-of-the-art Wet-labs

Our labs create a powerful feedback loop to the R&D lifecycle

  • Equipped for sciences: Biology, Chemistry, CMC, DMPK
  • Skilled drug discovery scientists
  • Investments in tech: CRISPR, RNA-sequencing, iPSC
  • Imaging and Cytometry
  • Secure data storage
  • Expanded capabilities with CRO's and academia

PARTNERING

Partner with the leading AI-pioneer in drug discovery

Speak to our team